Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). Microviable Team joins [...]
Technological advances in studying the human microbiome in depth have enabled the identification of microbial signatures associated with health and disease. This confirms the crucial role of microbiota in maintaining homeostasis and the host health [...]
Inmunobiota is one of the projects selected in CSIC-COCREA that seeks to develop products based on microbiota to combat infections and enhance the immune response. THE CHALLENGE Immunotherapy has improved the prognosis of lung cancer, [...]
From Microviable in the International Day of Women and Girls in Science, we want to speakup for all the female working in STEM (Science, Technology, Engineering and Mathematics), not only for their great work but [...]
Microviable Therapeutics, a biotechnology company dedicated to the development of new biotherapeutic products based on intestinal microbiota and established in the Gijón Scientific and Technological Park, has been chosen by the Association of Scientific and [...]
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and Pilar Manrique, PhD, Research Scientist, will be attending the 8th Microbiome Movement - Drug Development Summit Europe which will take place from 30 January to 1 February 2024 [...]
From Microviable we want to express our most sincere wishes for you and your loved ones this holiday season. May this Christmas your days be filled with laughter, your home with love and your heart [...]
The microbiota plays a crucial role in human health, directly influencing digestive functions, protection against pathogens, modulation of the immune system, and the production of essential vitamins and metabolites. In relation to oncological processes, numerous [...]
Clarivate a research organization and global expert in data insights and collection, recognizes the true pioneers in their fields over the last decade, demonstrated by the production of multiple highly-cited papers that rank in the [...]
Microviable Therapeutics will participate in Microbiome Connect USA that will take place from November 14th to 16th in Boston. Claudio Hidalgo Cantabrana, CEO at Microviable, will join a like-minded community of 300 scientists and entrepreneurs [...]